The U.S. is providing doses of an experimental antibody drug for clinical trials to combat the Ebola outbreak in the Democratic Republic of Congo, marking a shift in its policy.
The U.S. is providing doses of an experimental antibody drug for clinical trials to combat the Ebola outbreak in the Democratic Republic of Congo, marking a shift in its policy.